May 9, 2019
Promethera doses patients with HepaStem testing drug for Liver Stem Cell Therapy in Late-Stage NASH
Promethera doses patients with HepaStem drug testing it in late stage non-alcoholic steatohepatitis
Pharmaceuticals, Biotechnology and Life Sciences
Promethera doses patients with HepaStem drug testing it in late stage non-alcoholic steatohepatitis